Heartseed, Inc.
219A.T
Get informed when a big investor buys or sells
+ FollowMarket Cap$60.41B
Close$
Share Statistics
| Market cap | $60.41 Billion |
|---|---|
| Enterprise Value | $54.08 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $7.23 |
| Beta | 0.54 |
| Outstanding Shares | 22,897,400 |
Return
| Return on Equity | -10.04% |
|---|---|
| Return on Assets | -9.50% |
| Return on Invested Capital | -11.43% |
Valuation & Multiples
| P/E Ratio | -90.08 |
|---|---|
| PEG | 63.5 |
| Price to Sales | 38.84 |
| Price to Book Ratio | 9.11 |
| Enterprise Value to Revenue | 34.34 |
| Enterprise Value to EBIT | -69.31 |
| Enterprise Value to Net Income | -81 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 14, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$451.00 M
Average shareholder expectationNext Earnings Call
Expected Date
November 13, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$1.68 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Heartseed, Inc.
43 employees
CEO: Keiichi Fukuda Heartseed Inc. is a Japan-based company engaged in research and development of regenerative medicine products. The company has established cardiac regenerative medicine, a therapy in which microtissue derived from iPS cells is transplant...